Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of EP0031 in Patients With Advanced RET-altered Malignancies
Sponsor: Ellipses Pharma
Summary
The aim of this study is to assess the safety, side effects and effectiveness of EP0031 in patients with advanced RET-altered malignancies (NSCLC)
Official title: A Modular, Open-label, Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of EP0031 in Patients With Advanced RET-altered Malignancies
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
265
Start Date
2022-09-30
Completion Date
2027-06
Last Updated
2026-02-03
Healthy Volunteers
No
Conditions
Interventions
EP0031
EP0031 is a potent next-generation selective RET-inhibitor (SRI)
Locations (40)
David Geffen School of Medicine at UCLA
Los Angeles, California, United States
Stanford University
Stanford, California, United States
Georgetown University
Washington D.C., District of Columbia, United States
Florida Cancer Specialist
Fort Myers, Florida, United States
RUSH University Medical Center
Chicago, Illinois, United States
Northwestern University
Evanston, Illinois, United States
University of Kentucky
Lexington, Kentucky, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Karmanos
Detroit, Michigan, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
NYU Langone Health
New York, New York, United States
Providence Portland Medical Centre
Portland, Oregon, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Sarah Cannon
Nashville, Tennessee, United States
MD Anderson Cancer Center
Houston, Texas, United States
Virginia Cancer Specialists
Fairfax, Virginia, United States
Washington University
Seattle, Washington, United States
Seattle Cancer Care / Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
Assistance publique - Hôpitaux de Marseille
Marseille, Bouches-du-Rhône, France
Center Bergonié
Bordeaux, Gironde, France
Institut Gustave-Roussy
Villejuif, Paris, France
Centre François Baclesse
Caen, France
Centre Léon Bérard
Lyon, France
Charité Comprehensive Cancer Center
Berlin, Germany
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, Italy
Hospital Universitario de A Coruña
A Coruña, Spain
Hospital Universitario Vall d'Hebron
Barcelona, Spain
Hospital Universitario Insular de Gran Canaria
Las Palmas de Gran Canaria, Spain
Hospital Universitario Ramon y Cajal
Madrid, Spain
University Hospital October 12
Madrid, Spain
Hospital Madrid Sanchinarro
Madrid, Spain
Hospital Virgen de la Victoria de Malaga
Málaga, Spain
Tawam Hospital
Al Ain City, Abu Dhabi Emirate, United Arab Emirates
Sheik Shakhbout Medical City (SSMC)
Abu Dhabi, United Arab Emirates
Cleveland Clinic Abu Dhabi (CCAD)
Abu Dhabi, United Arab Emirates
University College London Hospital
London, United Kingdom
Guy's Hospital
London, United Kingdom
The Royal Marsden NHS Foundation Trust
London, United Kingdom
The Christie NHS Foundation Trust - Christie Hospital
Manchester, United Kingdom
Sheffield Teaching Hospitals NHS Foundation Trust
Sheffield, United Kingdom